{"id":1233,"date":"2023-07-05T14:04:18","date_gmt":"2023-07-05T14:04:18","guid":{"rendered":"https:\/\/innotech.uz\/?page_id=1233"},"modified":"2023-08-05T10:28:08","modified_gmt":"2023-08-05T10:28:08","slug":"ideos","status":"publish","type":"page","link":"https:\/\/innotech.uz\/uz\/ideos\/","title":{"rendered":"\u0418\u0434\u0435\u043e\u0441"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"1233\" class=\"elementor elementor-1233\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3840de7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3840de7\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-6746be4\" data-id=\"6746be4\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9565df9 elementor-widget elementor-widget-heading\" data-id=\"9565df9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">TIBBIYOTDA QO\u2019LLANILISHIGA DOIR YO\u2019RIQNOMA<br>\nIDEOS\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d2a5ce4 elementor-widget elementor-widget-text-editor\" data-id=\"d2a5ce4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Preparatning savdo nomi: <\/strong>Ideos<\/p><p><strong>Dori shakli: <\/strong>chaynaladigan tabletkalar<\/p><p><strong>Tarkibi:<\/strong><\/p><p>1 tabletka quyidagilarni saqlaydi:<\/p><p><em>faol moddalar: <\/em>kalsiy karbonati 1250 mg, bu 500 mg elementar kaltsiyga mos keladi, kolekaltsiferol (D3 vitamini) 400 XB (10 mkg)<\/p><p><em>yo<\/em><em>rdamchi moddalar: <\/em>ksilitol, povidon, magniy stearati, limon aromatizatori, sorbitol.<\/p><p>D3 vitaminining tarkibi: alfa-tokoferol, qisman gidrogenlangan soya moyi, jelatin, saxaroza, makkajo\u2019xori kraxmali.<\/p><p>Limon aromatizatori tarkibi: limon va apelsin efir moylari, liteya cubeda, maltodekstrin, akatsiya kamedi, natriy tsitrati.<\/p><p>Ushbu yordamchi moddalarga yuqori sezuvchanligi bo\u2019lgan va o\u2019zlashtiraolmaydigan patsientlarga e\u2019tibor berish kerak -\u201cMaxsus ko\u2019rsatmalar\u201d bo\u2019limiga qarang<\/p><p><strong>Ta\u2019rifi: <\/strong>oqdan kulrang-oq ranggacha bo\u2019lgan kvadrat tabletkalar.<\/p><p><strong>Farmakoterapevtik guruhi: <\/strong>kaltsiy preparatlari boshqa preparatlar bilan majmuada<\/p><p><strong>ATX kodi: <\/strong>A12AX<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Farmakologik xususiyatlari<\/strong><\/p><p><strong><em>Farmakodinamikasi <\/em><\/strong><\/p><p>Organizmda kalsiy va fosfor almashinuvini (suyak,tish, tirnoq, soch, mushaklarda) boshqaruvchi majmuaviy preparat. D3 vitamini me\u2019da-ichak yo\u2019llaridan kalsiyni so\u2019rilishini va uni suyak to\u2019qimasida bog\u2019lanishini oshiradi. Organizmda kalsiy va D3 vitaminining yetishmovchiligini<\/p><p>o\u2019rnini to\u2019ldirib, suyak to\u2019qimasining rezorbsiyasini (so\u2019rilib ketishini) kamaytiradi va zichligini oshiradi, tishlar mineralizatsiyasi uchun zarurdir. Kalsiy nerv o\u2019tkazuvchanligi, mushak qisqarishlarini boshqarishda ishtirok etadi va qon ivish tizimining komponenti hisoblanadi.<\/p><p>D3 vitamini ichakda kalsiy so\u2019rilishini oshiradi. Kalsiy va D3 vitaminini qo\u2019llash yuqori suyak rezorbsiyasini (suyakdan kalsiyni yuvib chiqarilishi) rag\u2019batlantiruvchisi hisoblangan paratireoid gormonini<\/p><p>(PTG) ishlab chiqarilishini oshishiga to\u2019sqinlik qiladi.<\/p><p><strong><em>Farmakokinetikasi<\/em><\/strong><\/p><p>Preparatning komponentlarini o\u2019zaro ta\u2019siri bilan bog\u2019liq. D3 vitamini ingichka ichakda so\u2019riladi. Kalsiy ionlangan holda faol D3- vitamininiga bog\u2019liq transport mexanizmi yordamida ichakning proksimal qismida so\u2019riladi.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Qo\u2019llanilishi<\/strong><\/p><ul><li>Kalsiy yoki D3 vitamini tanqisligini oldini olish va davolash;<\/li><li>Osteoporozni (menopauzal, senil, steroid, idiopatik va boshqa) oldini olish va majmuaviy davolash;<\/li><li>Davolashda kartikosteroidlar, sitostatiklar va tirishishiga qarshi preparatlar qo\u2019llaniladigan revmatik kasalligi bo\u2019lgan patsientlarda ikkilamchi osteoporozni oldini olish va davolash.<\/li><\/ul><p><strong>\u00a0<\/strong><\/p><p><strong>Qo\u2019llash usuli va dozalari<\/strong><\/p><p>Faqat kattalar uchun!<\/p><p>Davolashni boshlashdan oldin shifokor bilan maslahatlashing. O\u2019rtacha sutkalik doza, agar shifokorning boshqa ko\u2019rsatmalari bo\u2019lmasa, 2 tabletkani tashkil qiladi (1 tabletkadan ertalab va kechqurun). Tabletkalarni shimish yoki chaynash kerak.<\/p><p>Davolash kursining davolmiyligini kasallikni kechishiga qarab, shifokor belgilaydi.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Nojo\u2019ya ta`sirlari <\/strong><\/p><p>Barcha dorilar singari, ushbu preparat ham nojo&#8217;ya ta&#8217;sirlarni keltirib chiqarishi mumkin, ammo har bir bemor ularni his qilmaydi.<\/p><p>Ba&#8217;zan (100 odamdan 1 tasida kuzatiladi):<\/p><p>&#8212; Qon yoki siydikda kaltsiyning yuqori darajasi<\/p><p>\u00a0<\/p><p>Kam hollarda (1000 odamdan 1 tasida kuzatiladi):<\/p><p><strong>&#8212; <\/strong>qabziyat yoki ich ketishi, qorinni dam bo\u2019lishi, qorin og&#8217;rig&#8217;i, xolsizlik (ko\u2019ngil aynishi)<\/p><p><strong>&#8212; <\/strong>qichishish, teri toshmalari, eshakemi.<\/p><p>\u00a0<\/p><p>Noma&#8217;lum (mavjud ma&#8217;lumotlarga ko&#8217;ra, davriylikni baholash mumkin emas):<\/p><p><strong>&#8212; <\/strong>Qonda yuqori kaltsiy kontsentratsiyasi (giperkalsiemiya), yuqori qon pH (alkaloz) va buyrak etishmovchiligi bilan bog&#8217;liq bo&#8217;lgan sut-ishqoriy sindromi, preparatning katta dozalarini qabul qilishda paydo bo&#8217;lishi mumkin (qarang:&#187; maxsus ko&#8217;rsatmalar va ehtiyot choralari &#171;va &#171;IDEOS preparat miqdorini tavsiya etilganidan ko&#8217;ra ko&#8217;proq qabul qilganda&#187;)<\/p><p><strong>&#8212; <\/strong>Jiddiy allergik reaktsiyalar (yuqori sezuvchanlik), masalan, nafas olish qiyinlashishiga olib kelishi mumkin bo&#8217;lgan yuz, lablar, til yoki tomoqning shishishi (angionevrotik\u00a0 yoki laringeal shish)<\/p><p>\u00a0<\/p><p><strong>Nojo\u2019ya ta`sirlari xaqida xabarl<\/strong><strong>ar<\/strong><\/p><p>Nojo\u2019ya\u00a0 ta&#8217;sirlar paydo bo&#8217;lganda, shifokor yoki farmatsevt bilan maslahatlashing.<\/p><p>Bu ushbu yo&#8217;riqnomada ko&#8217;rsatilmagan har qanday nojo\u2019ya samaralarga nisbatan qo&#8217;llaniladi<\/p><p>Nojo\u2019ya\u00a0 ta&#8217;sirlar haqida to&#8217;g&#8217;ridan-to&#8217;g&#8217;ri mamlakatdagi Farmakonadzor bo&#8217;yicha milliy tizim orqali xabar berish mumkin. Nojo\u2019ya\u00a0 ta&#8217;sirlar haqidagi xabarlar ushbu preparatning xavfsizligi haqida ko&#8217;proq ma&#8217;lumot beradi.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Qo\u2019llash mumkin bo\u2019lmagan holatlar<\/strong><\/p><ul><li>Preparat komponentlariga yuqori sezuvchanlik;<\/li><li>Giperkalsiemiya (qonda kalsiy konsentratsiyasini oshishi);<\/li><li>Giperkalsiuriya (siydik bilan kalsiyni ko\u2019p ajralishi) va giperkalsiemiya yoki giperkalsiuriyaga olib keluvchi kasalliklar (masalan, mielom kasalligi, suyakdagi metastazlar, birlamchi giperparatireoz);<\/li><li>Siydik-tosh kasalligi (kalsiy toshlarini hosil bo\u2019lishi);<\/li><li>Uzoq vaqt immobilizatsiya bilan bog\u2019liq osteoporoz.<\/li><li>D gipervitaminozi<\/li><li>Buyrak yetishmovchiligi.<\/li><\/ul><p>Sarkaidozda preparatni qabul qilishda ehtiyotkorlikka<\/p><p>rioya qilish kerak.<\/p><p>\u00a0<\/p><p><strong>Dorilarning o\u2019zaro ta\u2019siri<\/strong><\/p><p>SHifokorga Siz qanday dori preparatlarini qabul qilayotganingiz haqida xabar berish kerak.<\/p><p>Dozani oshirib yuborilishidan saqlanish uchun boshqa manbalardan D3 vitaminini qo\u2019shimcha tushishini e\u2019tiborga olish kerak. Kalsiy va D3 vitaminini saqlovchi boshqa vitamin majmualari bilan bir vaqtda qo\u2019llash mumkin emas. Fenitoin, barbituratlar, glyukortikosteroidlar D3 vitaminining ta\u2019sirini kamaytiradi. Glyukokortikoidlar kalsiy so\u2019rilishini kamaytiradi.<\/p><p>Xolestiramin, orlistat, surgi vositalari (parafin moyi) D3 vitaminining so\u2019rilishi kamaytiradi. Ideos bifosfonatlar, natriy ftoridining so\u2019rilishini kamaytiradi, shuning uchun ushbu preparatlarni qabul qilish orasidagi interval kamida 2 soat bo\u2019lishi kerak.<\/p><p>Ideos tetratsiklin guruhi antibiotiklarining so\u2019rilishini kamaytiradi, shuning uchun ushbu preparatlarni qabul qilish orasidagi interval kamida 3 soat bo\u2019lishi kerak.<\/p><p>Ideos preparati bilan bir vaqtda qabul qilinganda yurak glikozidlarining toksikligi ortadi. EKG va klinik holatni muntazam nazorat qilish kerak. Estramustin, tireoid gormonlar, stronsiy, temir tuzlari, rux saqlovchi<\/p><p>preparatlar \u2013 preparatning biokiraolishliligini 60-70% ga kamayishi xavfi tufayli, Ideos preparati bilan qabul qilish orasidagi interval 2 soat bo\u2019lishi tavsiya qilinadi. Ideos preparatini tiazid diuretiklar bilan qabul qilishda giperkalsiemiya rivojlanishi xavfi ortadi.<\/p><p>Furosemid va boshqa \u201chalqali\u201d diuretiklar kalsiyni buyraklar orqali chiqarilishini oshiradi.<\/p><p>Soyaga yuqori sezuvchanlik, sorbitol va saxarozani o\u2019zlashtiraolmaslikda preparatni qabul qilishda ehtiyotkorlikka rioya qilish kerak. Agar Sizda qandni o\u2019zlashtiraolmaslik yoki soya yoki yeryong\u2019oqqa allergiya\u00a0 bo\u2019lsa, Ideos preparatini qo\u2019llash mumkinligi haqida shifokor bilan maslahatlashish uchun murojaat qiling.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Maxsus ko\u2019rsatmalar<\/strong><\/p><p>Davolash davrida kalsiyni siydik bilan chiqarilishi va plazmada kalsiy va kreatinin konsentratsiyasini doimiy nazorat qilish kerak. Sutkada 7,5 mmol dan ortiq kalsiuriya paydo bo\u2019lishi hollarida dozani kamaytirish yoki davolashni to\u2019xtatish kerak.<\/p><p>Keksa yoshli odamlarda kalsiyga bo\u2019lgan ehtiyoj sutkada 1,5 g ni, D3 vitaminiga bo\u2019lgan ehtiyoj 500-1000 XB ni tashkil qiladi.<\/p><p>Sarkoidoz, buyrak yetishmovchiligi yoki anamnezida qandni o\u2019zlashtiraolmaslikda\u00a0 Ideos\u00a0 preparatini qo\u2019llashdan oldin shifokorga murojaat qiling.<\/p><p>Dozani oshirib yuborilishidan saqlanish uchun boshqa manbalardan D3 vitaminini qo\u2019shimcha tushishini e\u2019tiborga olish kerak. Shovul kislotasi (shovul, ismaloq) fosfatlar (kolbasa mahsulotlari, sosiskalar, eritilganpishloq) va fitin kislotasini (yormasi) saqlovchi oziq-ovqat mahsulotlari kalsiyni so\u2019rilishini kamaytiradi, shuning uchun yuqoridagi sanab o\u2019tilgan mahsulotlarni qabul qilingandan keyin 2 soat davomida Ideosni qabul qilish mumkin emas.<\/p><p><em>Homiladorlik va emizish<\/em><\/p><p>Homiladorlikda sutkalik doza sutkada kalsiy 1500 mg va D3 vitamini 600 XB dan oshmasligi kerak.\u00a0 Homiladorlik vaqtida D3 vitaminining dozasini oshirib yuborilishi bolaning ruhiy va jismoniy rivojlanishini buzilishiga olib kelishi mumkin. Kalsiy va D3 vitamini ona sutiga kiradi.<\/p><p><em>Transport vositalarini boshqarish qobiliyatiga ta\u2019siri<\/em><\/p><p>Transport vositalari va boshqa mexanizmlarni boshqarish qobiliyatiga preparatning salbiy ta\u2019siri haqida ma\u2019lumotlar yo\u2019q.<\/p><p>Preparat bolalar olaolmaydigan joyda saqlansin va yaroqlilik muddati o\u2019tgach qo\u2019llanilmasin.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Dozani oshirib yuborilishi<\/strong><\/p><p>Dozani oshirib yuborilishining simptomlari: ko\u2019ngil aynishi, qusish, chanqoqlik, qabziyat, bosh aylanishi, hushdan ketish holatlari, xolsizlik,<\/p><p>giperkalsiuriya, giperkalsiemiya, buyrak yeishmovchiligi, giperkreatinemiya, yurak ritmini buzilishi.<\/p><p>Ortiqcha dozalarni uzoq muddat qo\u2019llanganda, qon tomirlari va to\u2019qimalarning kalsinozi bo\u2019lishi mumkin. Davolash: organizmga ko\u2019p miqdordagi suyuqlikni yuborish, halqali diuretiklarni (masalan, Furosemid), glyukokortikosteroidlar, kalsitonin, bifosfonatlarni<\/p><p>qo\u2019llash.<\/p><p>Dozani oshirib yuborilishi belgilari aniqlangan hollarda, yordam uchun shifokorga murojaat qiling. Dozani oshirib yuborilishining klinik simptomlari rivojlangan hollarda qonda kalsiy va kreatinin miqdorini aniqlash kerak. Qon zardobida kalsiy va kreatinin miqdori oshgan<\/p><p>hollarda davolashni to\u2019xtatish va shifokorga murojaat qilish kerak.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Chiqarilish shakli<\/strong><\/p><p>10 yoki 15 tabletkadan tubada.<\/p><p>2, 4, 5, 6, 10, 12 tuba tibbiyotda qo\u2019llanilishiga doir yo\u2019riqnomasi bilan birga qutida.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Saqlash sharoiti<\/strong><\/p><p>25\u00baC dan yuqori bo\u2019lmagan haroratda saqlansin.<\/p><p>Bolalar ololmaydigan joyda saqlansimn<\/p><p>\u00a0<\/p><p><strong>Yaroqlilik muddati<\/strong><\/p><p>3 yil.<\/p><p>Preparatni yaroqlilik muddati o\u2019tgach qo\u2019llanilmasin.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Dorixonalardan berish tartibi<\/strong><\/p><p>Retseptsiz.<\/p><p><strong>\u00a0<\/strong><\/p><p><strong>Ro\u2019yxatdan o\u2019tkazilganlik guvohnomasinig egasi<\/strong><\/p><p>Laboratoriya Innotek Internatsional<\/p><p>22, avenyu Aristid Brian, 94110 Arkey, Fransiya<\/p><p><strong>Ishlab chikaruvchi<\/strong><\/p><p>Innotera SHuzi<\/p><p>Ryu Rene Shantero, Shuzi-syur-Sis, Valuar-syur-Sis 41150, Fransiya.<\/p><p>\u00a0<\/p><p><strong>Uzbekiston Respublikasi xududida dori vositalarining sifatiga bo\u2019yicha e\u2019tirozlar (takliflar) ni qabul qiluvchi tashshkilot nomi va manzili:<\/strong><\/p><p>\u201cLaboratoriya Innotek Internasional\u201d Uzbekistondagi vakolatxonasi<\/p><ul><li>Yuridik manzili: Toshkent, Fidokor ko\u2019chasi 7A.<\/li><li>Tel.: 140-43-40, 140-43-41.<\/li><\/ul><p>E-mail: <a href=\"mailto:uz.innotech@sks.uz\">uz.innotech@sks.uz<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>\u0418\u041d\u0421\u0422\u0420\u0423\u041a\u0426\u0418\u042f \u041f\u041e \u041c\u0415\u0414\u0418\u0426\u0418\u041d\u0421\u041a\u041e\u041c\u0423 \u041f\u0420\u0418\u041c\u0415\u041d\u0415\u041d\u0418\u042e \u0418\u0414\u0415\u041e\u0421 \u0422\u043e\u0440\u0433\u043e\u0432\u043e\u0435 \u043d\u0430\u0437\u0432\u0430\u043d\u0438\u0435 \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430: \u0418\u0434\u0435\u043e\u0441 \u041b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u0430\u044f \u0444\u043e\u0440\u043c\u0430: \u0442\u0430\u0431\u043b\u0435\u0442\u043a\u0438 \u0436\u0435\u0432\u0430\u0442\u0435\u043b\u044c\u043d\u044b\u0435. \u0421\u043e\u0441\u0442\u0430\u0432: 1 \u0442\u0430\u0431\u043b\u0435\u0442\u043a\u0430 \u0441\u043e\u0434\u0435\u0440\u0436\u0438\u0442: \u0430\u043a\u0442\u0438\u0432\u043d\u044b\u0435 \u0432\u0435\u0449\u0435\u0441\u0442\u0432\u0430: \u043a\u0430\u043b\u044c\u0446\u0438\u044f \u043a\u0430\u0440\u0431\u043e\u043d\u0430\u0442 1250 \u043c\u0433, \u0447\u0442\u043e \u0441\u043e\u043e\u0442\u0432\u0435\u0442\u0441\u0442\u0432\u0443\u0435\u0442 500 \u043c\u0433 \u044d\u043b\u0435\u043c\u0435\u043d\u0442\u0430\u0440\u043d\u043e\u0433\u043e \u043a\u0430\u043b\u044c\u0446\u0438\u044f, \u0445\u043e\u043b\u0435\u043a\u0430\u043b\u044c\u0446\u0438\u0444\u0435\u0440\u043e\u043b (\u0432\u0438\u0442\u0430\u043c\u0438\u043d D3)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 400 M\u0415 (10 \u043c\u043a\u0433) \u0432\u0441\u043f\u043e\u043c\u043e\u0433\u0430\u0442\u0435\u043b\u044c\u043d\u044b\u0435 \u0432\u0435\u0449\u0435\u0441\u0442\u0432\u0430: \u043a\u0441\u0438\u043b\u0438\u0442\u043e\u043b, \u043f\u043e\u0432\u0438\u0434\u043e\u043d, \u043c\u0430\u0433\u043d\u0438\u044f \u0441\u0442\u0435\u0430\u0440\u0430\u0442, \u0430\u0440\u043e\u043c\u0430\u0442\u0438\u0437\u0430\u0442\u043e\u0440 \u043b\u0438\u043c\u043e\u043d\u043d\u044b\u0439, \u0441\u043e\u0440\u0431\u0438\u0442\u043e\u043b \u0421\u043e\u0441\u0442\u0430\u0432 \u0432\u0438\u0442\u0430\u043c\u0438\u043d\u0430 D3: \u0430\u043b\u044c\u0444\u0430-\u0442\u043e\u043a\u043e\u0444\u0435\u0440\u043e\u043b, \u0441\u043e\u0435\u0432\u043e\u0435 \u043c\u0430\u0441\u043b\u043e, \u0447\u0430\u0441\u0442\u0438\u0447\u043d\u043e \u0433\u0438\u0434\u0440\u043e\u0433\u0435\u043d\u0438\u0437\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0435, \u0436\u0435\u043b\u0430\u0442\u0438\u043d, \u0441\u0430\u0445\u0430\u0440\u043e\u0437\u0430,&hellip; <a class=\"more-link\" href=\"https:\/\/innotech.uz\/uz\/ideos\/\">Continue reading <span class=\"screen-reader-text\">\u0418\u0434\u0435\u043e\u0441<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-1233","page","type-page","status-publish","hentry","entry"],"_links":{"self":[{"href":"https:\/\/innotech.uz\/uz\/wp-json\/wp\/v2\/pages\/1233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innotech.uz\/uz\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/innotech.uz\/uz\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/innotech.uz\/uz\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/innotech.uz\/uz\/wp-json\/wp\/v2\/comments?post=1233"}],"version-history":[{"count":0,"href":"https:\/\/innotech.uz\/uz\/wp-json\/wp\/v2\/pages\/1233\/revisions"}],"wp:attachment":[{"href":"https:\/\/innotech.uz\/uz\/wp-json\/wp\/v2\/media?parent=1233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}